. 2023 Jul 27;13:12176. doi: 10.1038/s41598-023-38837-9

Table 1.

Nutritional parameters of different sub-groups at the end of the second stage of the experiment.

Groups	Parameters
Groups	IBW (g)	FBW (g)	BWG (g)	TFI (g)	FER
NC	207.5^a ± 4.4	246.8^a ± 3.57	39.3^a ± 1.46	378.3^a ± 13.04	0.104^a ± 0.005
MC	255.0^b ± 3.3	313.6^b ± 2.67	58.6^c ± 1.35	437.6^b ± 10.07	0.135^b ± 0.005
A	255.0^b ± 2.7	303.9^bc ± 1.96	48.9^b ± 1.09	418.4^ab ± 11.92	0.118^ab ± 0.005
N1	255.0^b ± 2.9	298.3^c ± 2.14	43.3^ab ± 1.35	408.9^ab ± 19.88	0.108^a ± 0.010
NN1	255.0^b ± 3.5	298.3^c ± 2.65	43.3^ab ± 1.86	390.3^ab ± 13.65	0.111^a ± 0.004
N2	255.0^b ± 3.7	304.0^c ± 2.77	49.0^b ± 2.27	403.8^ab ± 10.60	0.121^ab ± 0.004
NN2	255.0^b ± 3.3	301.0^c ± 2.98	46.0^ab ± 2.71	394.7^ab ± 11.20	0.116^ab ± 0.010
AN1	255.0^b ± 3.6	296.4^c ± 2.09	41.4^a ± 2.31	387.7^a ± 12.68	0.107^a ± 0.010
ANN1	255.0^b ± 3.8	296.9^c ± 2.96	41.9^a ± 2.38	377.2^a ± 8.54	0.112^a ± 0.010
AN2	255.0^b ± 2.5	298.3^c ± 2.35	43.3^ab ± 1.19	396.3^ab ± 7.99	0.110^a ± 0.010
ANN2	255.0^b ± 3.8	299.1^c ± 2.55	44.1^ab ± 1.39	395.7^ab ± 7.91	0.110^a ± 0.004

Values are expressed as means ± SE (n = 8). Significance was considered at p < 0.05 within columns where different letters indicate statistical significance.

NC control normal, MC metabolic syndrome control, A rats given atorvastatin drug, N1 rats received nutraceutical 1, NN1 Rats treated with nutraceutical 1nanostructure, N2 rats received nutraceutical 2, NN2 rats given nutraceutical 2 nanostructure, AN1 rats taken atorvastatin drug with nutraceutical 1, ANN1 rats given atorvastatin drug with nutraceutical 1 nanostructure, AN2 rats treated with atorvastatin drug with nutraceutical 2, ANN2 rats received atorvastatin drug with nutraceutical 2 nanostructure, IBW initial body weight, FBW final body weight, BWG body weight gain, TFI total food intake, FER food efficiency ratio.